CA2365909A1 - Compositions et methodes de depistage et de traitement du cancer du sein - Google Patents

Compositions et methodes de depistage et de traitement du cancer du sein Download PDF

Info

Publication number
CA2365909A1
CA2365909A1 CA002365909A CA2365909A CA2365909A1 CA 2365909 A1 CA2365909 A1 CA 2365909A1 CA 002365909 A CA002365909 A CA 002365909A CA 2365909 A CA2365909 A CA 2365909A CA 2365909 A1 CA2365909 A1 CA 2365909A1
Authority
CA
Canada
Prior art keywords
polynucleotide
dna
patient
seq
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002365909A
Other languages
English (en)
Inventor
Tony N. Frudakis
John M. Smith
Steven G. Reed
Lynda E. Misher
Marc W. Retter
Davin C. Dillon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/289,198 external-priority patent/US6586570B1/en
Priority claimed from US09/429,755 external-priority patent/US6656480B2/en
Priority claimed from US09/534,825 external-priority patent/US6861506B1/en
Application filed by Individual filed Critical Individual
Publication of CA2365909A1 publication Critical patent/CA2365909A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention porte sur des compositions et des méthodes de dépistage et de traitement du cancer du sein. Les compositions de l'invention comprennent des séquences nucléotidiques exprimées de préférence dans un tissu mammaire cancéreux, ainsi que des polypeptides codés par ces séquences nucléotidiques. L'invention porte également sur des vaccins et des compositions pharmaceutiques contenant lesdits composés et pouvant être utilisés, par exemple, pour la prévention et le traitement du cancer du sein. Ces polypeptides peuvent également être utilisés pour la production d'anticorps utiles pour le dépistage et la surveillance de l'évolution du cancer du sein chez une patiente.
CA002365909A 1999-04-09 2000-04-07 Compositions et methodes de depistage et de traitement du cancer du sein Abandoned CA2365909A1 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US09/289,198 US6586570B1 (en) 1996-01-11 1999-04-09 Compositions and methods for the treatment and diagnosis of breast cancer
US09/429,755 US6656480B2 (en) 1996-01-11 1999-10-28 Compositions and methods for the treatment and diagnosis of breast cancer
US09/534,825 2000-03-23
US09/429,755 2000-03-23
US09/534,825 US6861506B1 (en) 1996-01-11 2000-03-23 Compositions and methods for the treatment and diagnosis of breast cancer
US09/289,198 2000-03-23
PCT/US2000/009312 WO2000061753A2 (fr) 1999-04-09 2000-04-07 Compositions et methodes de depistage et de traitement du cancer du sein

Publications (1)

Publication Number Publication Date
CA2365909A1 true CA2365909A1 (fr) 2000-10-19

Family

ID=27403868

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002365909A Abandoned CA2365909A1 (fr) 1999-04-09 2000-04-07 Compositions et methodes de depistage et de traitement du cancer du sein

Country Status (15)

Country Link
EP (1) EP1169444A2 (fr)
JP (1) JP2002541803A (fr)
KR (1) KR20020026418A (fr)
CN (1) CN1352683A (fr)
AU (1) AU774824B2 (fr)
BR (1) BR0009573A (fr)
CA (1) CA2365909A1 (fr)
CZ (1) CZ20013575A3 (fr)
HU (1) HUP0200825A2 (fr)
IL (1) IL145719A0 (fr)
MX (1) MXPA01010186A (fr)
NO (1) NO20014805L (fr)
NZ (1) NZ514646A (fr)
PL (1) PL350863A1 (fr)
WO (1) WO2000061753A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7241876B2 (en) 1996-01-11 2007-07-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6656480B2 (en) 1996-01-11 2003-12-02 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6861506B1 (en) 1996-01-11 2005-03-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US20030125536A1 (en) * 1996-01-11 2003-07-03 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6586570B1 (en) 1996-01-11 2003-07-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US20020068285A1 (en) * 1996-01-11 2002-06-06 Frudakis Tony N. Compositions and methods for the therapy and diagnosis of breast cancer
US6828431B1 (en) 1999-04-09 2004-12-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
WO2004016733A2 (fr) 2002-08-16 2004-02-26 Agensys, Inc. Acides nucleiques et proteines correspondantes connues sous 251p5g2 que l'on utilise dans le traitement et la detection de cancers
CN111983220B (zh) * 2019-05-21 2024-03-19 北京中科纳泰生物科技有限公司 多肽磁性纳米颗粒、其制备方法及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997025431A1 (fr) * 1996-01-10 1997-07-17 Corixa Corporation Compositions et procedes de traitement et de diagnostic du cancer
JP2001501447A (ja) * 1996-01-11 2001-02-06 コリクサ コーポレイション 乳癌の処置および診断のための組成物および方法
ZA982968B (en) * 1997-04-09 1998-10-27 Corixa Corp Compositions and methods for the treatment and diagnosis of breast cancer
EP1037977B1 (fr) * 1997-12-17 2009-08-26 Serono Genetics Institute S.A. ADNc PROLONGES POUR PROTEINES SECRETEES
KR20010083111A (ko) * 1998-07-14 2001-08-31 길리스 스티브 전립선암의 치료 및 진단을 위한 조성물 및 방법

Also Published As

Publication number Publication date
BR0009573A (pt) 2002-04-16
NZ514646A (en) 2005-04-29
EP1169444A2 (fr) 2002-01-09
KR20020026418A (ko) 2002-04-10
NO20014805D0 (no) 2001-10-03
CN1352683A (zh) 2002-06-05
PL350863A1 (en) 2003-02-10
AU4213000A (en) 2000-11-14
HUP0200825A2 (en) 2002-07-29
WO2000061753A3 (fr) 2001-06-28
CZ20013575A3 (cs) 2002-10-16
WO2000061753A2 (fr) 2000-10-19
IL145719A0 (en) 2002-07-25
JP2002541803A (ja) 2002-12-10
MXPA01010186A (es) 2004-08-12
AU774824B2 (en) 2004-07-08
NO20014805L (no) 2001-12-06

Similar Documents

Publication Publication Date Title
AU728777B2 (en) Compositions and methods for the treatment and diagnosis of breast cancer
EP1870466A2 (fr) Compositions et procédés pour le traitement et le diagnostic du cancer de la prostate
WO1997025426A9 (fr) Compositions et procedes pour le traitement et le diagnostic du cancer du sein
EP2028190A1 (fr) Composés et procédés de thérapie et de diagnostic du cancer du poumon
US20110150883A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
EP1127893A2 (fr) Compositions thérapeutiques et diagnostiques du carcinome mammaire et méthodes afférentes
US6410507B1 (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
CA2365909A1 (fr) Compositions et methodes de depistage et de traitement du cancer du sein
US6828431B1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
US20020068285A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
US6586570B1 (en) Compositions and methods for the treatment and diagnosis of breast cancer
US20020111467A1 (en) Compositions and methods for the treatment and diagnosis of breast cancer
US6861506B1 (en) Compositions and methods for the treatment and diagnosis of breast cancer
US6423496B1 (en) Compositions and methods for the treatment and diagnosis of breast cancer
AU2004218695B2 (en) Compositions and methods for the treatment and diagnosis of breast cancer
US20020165371A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
US20040073016A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2008201853A1 (en) Compositions and methods for the treatment and diagnosis of breast cancer
US7270980B2 (en) Compounds for immunodiagnosis of prostate cancer and methods for their use
AU7150600A (en) Compositions and methods for the treatment and diagnosis of breast cancer
MXPA98005611A (en) Compositions and methods for the treatment and diagnosis of m cancer
CA2613125A1 (fr) Compositions et methodes de therapie et de diagnostic du cancer de la prostate

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued